A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Features and development of Coot

Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. D. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 27,510 · see citing works

<i>PHENIX</i> : a comprehensive Python-based system for macromolecular structure solution

Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716 · see citing works

<i>Phaser</i> crystallographic software

McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612 · see citing works

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334 · see citing works

How good are my data and what is the resolution?

Evans, P. R., & Murshudov, G. N. (2013) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444913000061 · Cited by 4,747 · see citing works

iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM

Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R., & Leslie, A. G. W. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910048675 · Cited by 2,869 · see citing works

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773 · see citing works

The Burden of Respiratory Syncytial Virus Infection in Young Children

Hall, C. B., Weinberg, G. A., Iwane, M. K., Blumkin, A. K., Edwards, K. M., Staat, M. A., Auinger, P., Griffin, M. R., Poehling, K. A., Erdman, D. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804877 · Cited by 2,250 · see citing works

Risk of Primary Infection and Reinfection With Respiratory Syncytial Virus

Glezen, W. P. (1986) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1986.02140200053026 · Cited by 1,533 · see citing works

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

McLellan, J. S., Chen, M., Joyce, M. G., Sastry, M., Stewart-Jones, G. B. E., Yang, Y., Zhang, B., Chen, L., Srivatsan, S., Zheng, A., et al. (2013) · Science · doi:10.1126/science.1243283 · Cited by 1,126 · see citing works

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

McLellan, J. S., Chen, M., Leung, S., Graepel, K. W., Du, X., Yang, Y., Zhou, T., Baxa, U., Yasuda, E., Beaumont, T., et al. (2013) · Science · doi:10.1126/science.1234914 · Cited by 883 · see citing works

Appion: An integrated, database-driven pipeline to facilitate EM image processing

Lander, G. C., Stagg, S. M., Voss, N. R., Cheng, A., Fellmann, D., Pulokas, J., Yoshioka, C., Irving, C., Mulder, A. M., Lau, P., et al. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.01.002 · Cited by 836 · see citing works

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

Johnson, S., Oliver, C. N., Prince, G. A., Hemming, V. G., Pfarr, D. S., Wang, S., Dormitzer, M., O'Grady, J., Koenig, S., Tamura, J. K., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514115 · Cited by 642 · see citing works

Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008

Zhou, H., Thompson, W., Viboud, C. G., Ringholz, C., Cheng, P.-Y., Steiner, C., Abedi, G. R., Anderson, L. J., Brammer, L., & Shay, D. K. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis211 · Cited by 573 · see citing works

XMIPP: a new generation of an open-source image processing package for electron microscopy

Sorzano, C. Ó. S., Marabini, R., Velázquez-Muriel, J. A., Bilbao-Castro, J. R., Scheres, S. H. W., Carazo, J. M., & Pascual-Montano, A. (2004) · Journal of Structural Biology · doi:10.1016/j.jsb.2004.06.006 · Cited by 469 · see citing works

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

Collins, P. L., & Melero, J. A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.020 · Cited by 455 · see citing works

Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1

Sanders, R. W., Vesanen, M., Schülke, N., Master, A., Schiffner, L., Kalyanaraman, R., Paluch, M. T., Berkhout, B., Maddon, P. J., Olson, W. C., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8875-8889.2002 · Cited by 441 · see citing works

Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation

Yin, H.-S., Wen, X., Paterson, R. G., Lamb, R. A., & Jardetzky, T. S. (2006) · Nature · doi:10.1038/nature04322 · Cited by 418 · see citing works

The Many Mechanisms of Viral Membrane Fusion Proteins

Earp, L. J., Delos, S. E., Park, H. E., & White, J. M. (2004) · Current topics in microbiology and immunology · doi:10.1007/3-540-26764-6_2 · Cited by 381 · see citing works

Development of Motavizumab, an Ultra-potent Antibody for the Prevention of Respiratory Syncytial Virus Infection in the Upper and Lower Respiratory Tract

Wu, H., Pfarr, D. S., Johnson, S., Brewah, Y. A., Woods, R. M., Patel, N., White, W. I., Young, J. F., & Kiener, P. A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.024 · Cited by 374 · see citing works

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

Olmsted, R. A., Elango, N., Prince, G. A., Murphy, B. R., Johnson, P. R., Moss, B., Chanock, R. M., & Collins, P. L. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7462 · Cited by 321 · see citing works

Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein

Yin, H.-S., Paterson, R. G., Wen, X., Lamb, R. A., & Jardetzky, T. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503989102 · Cited by 312 · see citing works

Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming

Kwakkenbos, M. J., Diehl, S. A., Yasuda, E., Bakker, A. Q., van Geelen, C. M. M., Lukens, M. V., van Bleek, G. M., Widjojoatmodjo, M. N., Bogers, W. M. J. M., Mei, H. E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2071 · Cited by 297 · see citing works

The pathogenesis of respiratory syncytial virus infection in cotton rats.

Prince, G. A., Jenson, A. B., Horswood, R. L., Camargo, E., & Chanock, R. M. (1978) · PubMed Central · Cited by 296 · see citing works

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

Swanson, K. A., Settembre, E. C., Shaw, C. A., Dey, A. K., Rappuoli, R., Mandl, C. W., Dormitzer, P. R., & Carfi, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106536108 · Cited by 285 · see citing works

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

Corti, D., Bianchi, S., Zatta, F., Minola, A., Perez, L. H., Agatic, G., Guarino, B., Silacci, C., Marcandalli, J., Marsland, B. J., et al. (2013) · Nature · doi:10.1038/nature12442 · Cited by 274 · see citing works

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

Magro, M., Mas, V., Chappell, K., Vázquez, M., Cano, O., Luque, D., Terrón, M. C., Melero, J. A., & Palomo, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115941109 · Cited by 271 · see citing works

Architecture of respiratory syncytial virus revealed by electron cryotomography

Liljeroos, L., Krzyzaniak, M. A., Helenius, A., & Butcher, S. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309070110 · Cited by 214 · see citing works

Structural basis of respiratory syncytial virus neutralization by motavizumab

McLellan, J. S., Chen, M., Kim, A., Yang, Y., Graham, B. S., & Kwong, P. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1723 · Cited by 182 · see citing works

Activation of paramyxovirus membrane fusion and virus entry

Jardetzky, T. S., & Lamb, R. A. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.01.005 · Cited by 153 · see citing works

Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats

Smith, G., Raghunandan, R., Wu, Y., Liu, Y., Massare, M. J., Nathan, M., Zhou, B., Lu, H., Boddapati, S., Li, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050852 · Cited by 149 · see citing works

Structure of a Major Antigenic Site on the Respiratory Syncytial Virus Fusion Glycoprotein in Complex with Neutralizing Antibody 101F

McLellan, J. S., Chen, M., Chang, J., Yang, Y., Kim, A., Graham, B. S., & Kwong, P. D. (2010) · Journal of Virology · doi:10.1128/jvi.01579-10 · Cited by 129 · see citing works

Diversifying animal models: the use of hispid cotton rats ( Sigmodon hispidus ) in infectious diseases

Niewiesk, S., & Prince, G. A. (2002) · Laboratory Animals · doi:10.1258/002367702320389026 · Cited by 115 · see citing works

Structure of the Newcastle disease virus F protein in the post-fusion conformation

Swanson, K. A., Wen, X., Leser, G. P., Paterson, R. G., Lamb, R. A., & Jardetzky, T. S. (2010) · Virology · doi:10.1016/j.virol.2010.03.050 · Cited by 92 · see citing works

Pulmonary lesions in primary respiratory syncytial virus infection, reinfection, and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus).

Prince, G. A., Prieels, J., Slaoui, M., & Porter, D. D. (1999) · PubMed · Cited by 91 · see citing works

Engineering trimeric fibrous proteins based on bacteriophage T4 adhesins

Анатольевич, М. К., Marusich, E., Cerritelli, M. E., Cheng, N., Hyde, C. C., Steven, A. C., & Mesyanzhinov, V. V. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.4.329 · Cited by 57 · see citing works

The Cotton Rat Sigmodon Hispidus Model of Respiratory Syncytial Virus Infection

Boukhvalova, M. S., & Blanco, J. C. G. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-38919-1_17 · Cited by 48 · see citing works

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555 · see citing works

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

Hsieh, C.-L., Goldsmith, J. A., Schaub, J. M., DiVenere, A. M., Kuo, H.-C., Javanmardi, K., Le, K. C., Wrapp, D., Lee, A. G., Liu, Y., et al. (2020) · Science · doi:10.1126/science.abd0826 · Cited by 1,303 · see citing works

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073 · see citing works

Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment

Griffiths, C. D., Drews, S. J., & Marchant, D. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00010-16 · Cited by 599 · see citing works

The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates

Mazur, N. I., Higgins, D., Nunes, M. C., Melero, J. A., Langedijk, A. C., Horsley, N., Buchholz, U. J., Openshaw, P., McLellan, J. S., Englund, J. A., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30292-5 · Cited by 462 · see citing works

Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus

Marcandalli, J., Fiala, B., Ols, S., Perotti, M., de van der Schueren, W. J., Snijder, J., Hodge, E. A., Benhaim, M., Ravichandran, R., Carter, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.046 · Cited by 431 · see citing works

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

Mazur, N. I., Terstappen, J., Baral, R., Bardají, A., Beutels, P., Buchholz, U. J., Cohen, C., Crowe, J. E., Cutland, C., Eckert, L. O., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00291-2 · Cited by 423 · see citing works

Respiratory syncytial virus entry and how to block it

Battles, M., & McLellan, J. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0149-x · Cited by 358 · see citing works

Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity

Gobeil, S., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Stalls, V., Kopp, M., Manne, K., Li, D., Wiehe, K. J., et al. (2021) · Science · doi:10.1126/science.abi6226 · Cited by 374 · see citing works

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

(2020) · npj Vaccines · doi:10.1038/s41541-020-00243-x · Cited by 351 · see citing works

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction

Gobeil, S., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Manne, K., Stalls, V., Kopp, M., Henderson, R. C., Edwards, R. J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108630 · Cited by 320 · see citing works

Antibodies to combat viral infections: development strategies and progress

Pantaleo, G., Correia, B. E., Fenwick, C. W., Joo, V., & Perez, L. H. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00495-3 · Cited by 286 · see citing works

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors

Gilman, M. S. A., Castellanos, C. A., Chen, M., Ngwuta, J. O., Goodwin, E. C., Moin, S. M., Más, V., Melero, J. A., Wright, P. F., Graham, B. S., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaj1879 · Cited by 239 · see citing works

Structure-Based Vaccine Antigen Design

Graham, B. S., Gilman, M. S. A., & McLellan, J. S. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-121217-094234 · Cited by 234 · see citing works

Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines

Rey, F. A., & Lok, S. (2018) · Cell · doi:10.1016/j.cell.2018.02.054 · Cited by 232 · see citing works

Structural basis for antibody-mediated neutralization of Lassa virus

Hastie, K. M., Zandonatti, M. A., Kleinfelter, L. M., Heinrich, M. L., Rowland, M. M., Chandran, K., Branco, L. M., Robinson, J. E., Garry, R. F., & Saphire, E. O. (2017) · Science · doi:10.1126/science.aam7260 · Cited by 208 · see citing works

Influence of protein fold stability on immunogenicity and its implications for vaccine design

Scheiblhofer, S., Laimer, J., Machado, Y. J., Weiss, R., & Thalhamer, J. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1306441 · Cited by 203 · see citing works

Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection

Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre‐Bosquet, N., Grobben, M., Claireaux, M. A. F., de Gast, M., Marlin, R., Chesnais, V., Diry, S., et al. (2020) · Cell · doi:10.1016/j.cell.2021.01.035 · Cited by 182 · see citing works

Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection

Espeseth, A. S., Cejas, P. J., Citron, M. P., Wang, D., DiStefano, D. J., Callahan, C., Donnell, G. O., Galli, J. D., Swoyer, R., Touch, S., et al. (2020) · npj Vaccines · doi:10.1038/s41541-020-0163-z · Cited by 190 · see citing works

Respiratory syncytial virus infection and novel interventions

Langedijk, A. C., & Bont, L. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00919-w · Cited by 179 · see citing works

Molecular mechanism of respiratory syncytial virus fusion inhibitors

Battles, M. B., Langedijk, J. P. M., Furmanova, P., Chaiwatpongsakorn, S., Costello, H. M., Kwanten, L., Vranckx, L., Vink, P. M., Jaensch, S., Jonckers, T. H. M., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1982 · Cited by 176 · see citing works

Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV

Joyce, M. G., Zhang, B., Ou, L., Chen, M., Chuang, G., Druz, A., Kong, W., Lai, Y., Rundlet, E. J., Tsybovsky, Y., et al. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3267 · Cited by 168 · see citing works

Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children

Simões, E. A. F., Bont, L., Manzoni, P., Fauroux, B., Paes, B. A., Aloy, J. F., Checchia, P. A., & Carbonell‐Estrany, X. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0188-z · Cited by 158 · see citing works

Stabilizing the closed SARS-CoV-2 spike trimer

Juraszek, J., Rutten, L., Blokland, S., Bouchier, P., Voorzaat, R., Ritschel, T., Bakkers, M. J. G., Renault, L. L. R., & Langedijk, J. P. M. (2021) · Nature Communications · doi:10.1038/s41467-020-20321-x · Cited by 152 · see citing works

Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus

Killikelly, A. M., Kanekiyo, M., & Graham, B. S. (2016) · Scientific Reports · doi:10.1038/srep34108 · Cited by 151 · see citing works

Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation

Goodwin, E. C., Gilman, M., Wrapp, D., Chen, M., Ngwuta, J. O., Moin, S., Bai, P., Sivasubramanian, A., Connor, R., Wright, P., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.005 · Cited by 146 · see citing works

Respiratory Syncytial Virus: The Influence of Serotype and Genotype Variability on Clinical Course of Infection

Vandini, S., Biagi, C., & Lanari, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081717 · Cited by 146 · see citing works

Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development

Petersen, R. (2017) · Biosensors · doi:10.3390/bios7040049 · Cited by 140 · see citing works

Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability

Kong, L., He, L., de Val, N., Vora, N., Morris, C. D., Azadnia, P., Sok, D., Zhou, B., Burton, D. R., Ward, A. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12040 · Cited by 129 · see citing works

Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein

Battles, M. B., Más, V., Olmedillas, E., Cano, O., Vázquez, M., Laura, R., Melero, J. A., & McLellan, J. S. (2017) · Nature Communications · doi:10.1038/s41467-017-01708-9 · Cited by 121 · see citing works

Transient opening of trimeric prefusion RSV F proteins

Gilman, M. S. A., Furmanova, P., Pascual, G., Wout, A. B. V. ’., Langedijk, J. P. M., & McLellan, J. S. (2019) · Nature Communications · doi:10.1038/s41467-019-09807-5 · Cited by 119 · see citing works

A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain

Swanson, K. A., Rainho-Tomko, J. N., Williams, Z. P., Lanza, L., Peredelchuk, M., Kishko, M., Pavot, V., Alamares-Sapuay, J. G., Adhikarla, H., Gupta, S., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba6466 · Cited by 115 · see citing works

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)

Gatt, D., Martin, I., AlFouzan, R., & Moraes, T. J. (2023) · Pathogens · doi:10.3390/pathogens12020154 · Cited by 114 · see citing works

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

Mousa, J. J., Kose, N., Matta, P., Gilchuk, P., & Crowe, J. E. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.271 · Cited by 111 · see citing works

An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

Dang, H. V., Chan, Y., Park, Y., Snijder, J., Silva, S. C. D., Vu, B. K., Yan, L., Feng, Y.-R., Rockx, B., Geisbert, T. W., et al. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0308-9 · Cited by 110 · see citing works

Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years

Williams, K. L., Bastian, A. R., Feldman, R., Omoruyi, E. V. E., Paepe, E. D., Hendriks, J., van Zeeburg, H., Godeaux, O., Langedijk, J. P. M., Schuitemaker, H., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa193 · Cited by 108 · see citing works

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation

Stobart, C. C., Rostad, C. A., Ke, Z., Dillard, R. S., Hampton, C. M., Strauss, J. D., Yi, H. L., Hotard, A. L., Meng, J., Pickles, R. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13916 · Cited by 105 · see citing works

The Morphology and Assembly of Respiratory Syncytial Virus Revealed by Cryo-Electron Tomography

Ke, Z., Dillard, R. S., Chirkova, T., Leon, F., Stobart, C. C., Hampton, C. M., Strauss, J. D., Rajan, D., Rostad, C. A., Taylor, J. V., et al. (2018) · Viruses · doi:10.3390/v10080446 · Cited by 103 · see citing works

Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine

Che, Y., Gribenko, A. V., Song, X., Handke, L. D., Efferen, K. S., Tompkins, K. R., Kodali, S., Nuñez, L., Prasad, A. K., Phelan, L., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade6422 · Cited by 103 · see citing works

Virus vaccines: proteins prefer prolines

Sanders, R. W., & Moore, J. P. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.02.002 · Cited by 102 · see citing works

A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers

Rutten, L., Lai, Y., Blokland, S., Truan, D., Bisschop, I. J. M., Strokappe, N. M., Koornneef, A., van Manen, D., Chuang, G., Farney, S. K., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.061 · Cited by 101 · see citing works

EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression

Currier, M. G., Lee, S., Stobart, C. C., Hotard, A. L., Villenave, R., Meng, J., Pretto, C. D., Shields, M. D., Nguyen, M. T., Todd, S. O., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005622 · Cited by 100 · see citing works

Stabilized coronavirus spike stem elicits a broadly protective antibody

Hsieh, C., Werner, A. P., Leist, S. R., Stevens, L. J., Falconer, E., Goldsmith, J. A., Chou, C., Abiona, O. M., West, A., Westendorf, K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109929 · Cited by 99 · see citing works

Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4

Stewart-Jones, G. B. E., Chuang, G., Xu, K. Y., Zhou, T., Acharya, P., Tsybovsky, Y., Ou, L., Zhang, B., Fernandez-Rodriguez, B. M., Gilardi, V., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811980115 · Cited by 98 · see citing works

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

Roymans, D., Alnajjar, S., Battles, M. B., Sitthicharoenchai, P., Furmanova, P., Rigaux, P., Berg, J. V. D., Kwanten, L., Ginderen, M. V., Verheyen, N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00170-x · Cited by 97 · see citing works

Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants

Muñoz, F. M., Swamy, G. K., Hickman, S. P., Agrawal, S., Piedra, P. A., Glenn, G. M., Patel, N., August, A., Cho, I., & Fries, L. F. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz390 · Cited by 97 · see citing works

Vaccines against respiratory syncytial virus: The time has finally come

Graham, B. S. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.04.083 · Cited by 93 · see citing works

The Hantavirus Surface Glycoprotein Lattice and Its Fusion Control Mechanism

Serris, A., Stass, R., Bignon, E. A., Muena, N. A., Manuguerra, J., Jangra, R. K., Li, S., Chandran, K., Tischler, N. D., Huiskonen, J. T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.023 · Cited by 93 · see citing works

Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches

Taleb, S., Thani, A. A. A., Alansari, K., & Yassine, H. M. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3289-4 · Cited by 90 · see citing works

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

SADOFF, J. C., Paepe, E. D., DeVincenzo, J. P., Gymnopoulou, E., Menten, J., Murray, B. J., Bastian, A. R., Vandebosch, A., Haazen, W., Noulin, N., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab003 · Cited by 89 · see citing works

Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins

Hsieh, C., Rush, S. A., Palomo, C., Chou, C., Pickens, W., Más, V., & McLellan, J. S. (2022) · Nature Communications · doi:10.1038/s41467-022-28931-3 · Cited by 88 · see citing works

The prefusion structure of herpes simplex virus glycoprotein B

Vollmer, B., Pražák, V., Vasishtan, D., Jefferys, E. E., Durán, A. H., Vallbracht, M., Klupp, B. G., Mettenleiter, T. C., Backović, M., Rey, F. A., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc1726 · Cited by 85 · see citing works

Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses

Ols, S., Lenart, K., Cerveira, R. A., Miranda, M. C., Brunette, N., Kochmann, J., Corcoran, M., Skotheim, R., Philomin, A., Cagigi, A., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.08.011 · Cited by 80 · see citing works

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development

Boyoglu-Barnum, S., Chirkova, T., & Anderson, L. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01675 · Cited by 82 · see citing works

Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins

Fuentes, S., Coyle, E. M., Beeler, J. A., Golding, H., & Khurana, S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005554 · Cited by 77 · see citing works

Ongoing developments in RSV prophylaxis: a clinician’s analysis

Rezaee, F., Linfield, D. T., Harford, T. J., & Piedimonte, G. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.03.015 · Cited by 76 · see citing works

Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development

Melero, J. A., Más, V., & McLellan, J. S. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.045 · Cited by 73 · see citing works

Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies

Hu, M., Bogoyevitch, M. A., & Jans, D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00030.2019 · Cited by 72 · see citing works

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein

Tian, D., Battles, M. B., Moin, S. M., Chen, M., Modjarrad, K., Kumar, A., Kanekiyo, M., Graepel, K. W., Taher, N. M., Hotard, A. L., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01858-w · Cited by 71 · see citing works

Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf

McGill, J. L., Kelly, S. M., Kumar, P., Speckhart, S. L., Haughney, S. L., Henningson, J. N., Narasimhan, B., & Sacco, R. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-21292-2 · Cited by 70 · see citing works

Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers

Rutten, L., Gilman, M. S. A., Blokland, S., Juraszek, J., McLellan, J. S., & Langedijk, J. P. M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.025 · Cited by 70 · see citing works

The road to approved vaccines for respiratory syncytial virus

Ruckwardt, T. J. (2023) · npj Vaccines · doi:10.1038/s41541-023-00734-7 · Cited by 70 · see citing works

New Vaccine Design and Delivery Technologies

Kanekiyo, M., Ellis, D., & King, N. P. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy745 · Cited by 69 · see citing works

Clinical Potential of Prefusion RSV F-specific Antibodies

Rossey, I., McLellan, J. S., Saelens, X., & Schepens, B. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.09.009 · Cited by 69 · see citing works

Bacterial Vaccine Antigen Discovery in the Reverse Vaccinology 2.0 Era: Progress and Challenges

Bidmos, F. A., Siris, S., Gladstone, C. A., & Langford, P. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02315 · Cited by 68 · see citing works

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Mukhamedova, M., Wrapp, D., Shen, C., Gilman, M. S. A., Ruckwardt, T. J., Schramm, C. A., Ault, L., Chang, L. A., Derrien-Colemyn, A., Lucas, S. A. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.004 · Cited by 68 · see citing works

Protein engineering strategies for rational immunogen design

Caradonna, T. M., & Schmidt, A. G. (2021) · npj Vaccines · doi:10.1038/s41541-021-00417-1 · Cited by 68 · see citing works

Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions

Milder, F. J., Jongeneelen, M. A. C., Ritschel, T., Bouchier, P., Bisschop, I. J. M., de Man, M., Veldman, D., Le, L., Kaufmann, B., Bakkers, M. J. G., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2115379119 · Cited by 60 · see citing works

Global Outbreaks and Origins of a Chikungunya Virus Variant Carrying Mutations Which May Increase Fitness for Aedes aegypti: Revelations from the 2016 Mandera, Kenya Outbreak

Berry, I. M., Eyase, F. L., Pollett, S., Konongoi, S. L., Joyce, M. G., Figueroa, K., Ofula, V., Koka, H., Koskei, E., Nyunja, A., et al. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-0980 · Cited by 58 · see citing works

Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies

Kudlacek, S. T., Metz, S., Thiono, D., Payne, A. M., Phan, T. T. N., Tian, S., Forsberg, L. J., Maguire, J. B., Seim, I., Zhang, S., et al. (2021) · Science Advances · doi:10.1126/sciadv.abg4084 · Cited by 57 · see citing works

Principles and practical applications of structure-based vaccine design

Byrne, P. O., & McLellan, J. S. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102209 · Cited by 56 · see citing works

Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus

Sastry, M., Zhang, B., Chen, M., Joyce, M. G., Kong, W., Chuang, G., Ko, K., Kumar, A., Silacci, C., Thom, M. L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186854 · Cited by 56 · see citing works

Alternative conformations of a major antigenic site on RSV F

Jones, H. G., Battles, M. B., Lin, C.-C., Bianchi, S., Corti, D., & McLellan, J. S. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007944 · Cited by 56 · see citing works

The Journey to RSV Vaccines — Heralding an Era of Structure-Based Design

Graham, B. S. (2023) · New England Journal of Medicine · doi:10.1056/nejmp2216358 · Cited by 55 · see citing works

Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2

Watterson, D., Wijesundara, D. K., Modhiran, N., Mordant, F. L., Li, Z., Avumegah, M. S., McMillan, C. L. D., Lackenby, J. A., Guilfoyle, K. A., van Amerongen, G., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1269 · Cited by 54 · see citing works

Precise targeting of HIV broadly neutralizing antibody precursors in humans

Caniels, T. G., Prabhakaran, M. S., Ozorowski, G., MacPhee, K. J., Wu, W., van der Straten, K., Agrawal, S., Derking, R., Reiss, E. I. M. M., Millard, K. G., et al. (2025) · Science · doi:10.1126/science.adv5572 · Cited by 56 · see citing works

Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein

Mousa, J. J., Sauer, M. F., Sevy, A. M., Finn, J. A., Bates, J. T., Alvarado, G. S., King, H. G., Loerinc, L. B., Fong, R. H., Doranz, B. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609449113 · Cited by 53 · see citing works

Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSV

Widjaja, I., Wicht, O., Luytjes, W., Leenhouts, K. J., Rottier, P. J. M., van Kuppeveld, F. J. M., Haijema, B. J., & de Haan, C. A. M. (2016) · Journal of Virology · doi:10.1128/jvi.00235-16 · Cited by 52 · see citing works

Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults

SADOFF, J. C., Paepe, E. D., Haazen, W., Omoruyi, E. V. E., Bastian, A. R., Comeaux, C. A., Heijnen, E., Strout, C. B., Schuitemaker, H., & Callendret, B. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa409 · Cited by 52 · see citing works

The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development

Sun, C., Chen, X., Kang, Y., & Zeng, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.677027 · Cited by 52 · see citing works

Antibody Epitopes of Pneumovirus Fusion Proteins

Huang, J., Diaz, D., & Mousa, J. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02778 · Cited by 46 · see citing works

Protection of calves by a prefusion-stabilized bovine RSV F vaccine

Zhang, B., Lei, C., Silacci, C., Thom, M. L., Boyington, J. C., Druz, A., Joyce, M. G., Guzman, E., Kong, W., Lai, Y., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0005-9 · Cited by 46 · see citing works

Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development

Bigay, J., Grand, R. L., Martinon, F., & Maisonnasse, P. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.932408 · Cited by 51 · see citing works

Toward rational vaccine engineering

Vishweshwaraiah, Y. L., & Dokholyan, N. V. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114142 · Cited by 45 · see citing works

Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis

Jorquera, P. A., Anderson, L. J., & Tripp, R. A. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1115353 · Cited by 45 · see citing works

Antibody-guided structure-based vaccines

Kwong, P. D., DeKosky, B. J., & Ulmer, J. B. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101428 · Cited by 43 · see citing works

Human antibody recognition of antigenic site IV on Pneumovirus fusion proteins

Mousa, J. J., Binshtein, E., Human, S., Fong, R. H., Alvarado, G. S., Doranz, B. J., Moore, M. L., Ohi, M. D., & Crowe, J. E. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006837 · Cited by 44 · see citing works

Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane

Tang, W. F., Li, M., Liu, Y., Liang, N., Yang, Z., Zhao, Y., Wu, S., Lu, S., Li, Y.-L., & Liu, F. (2018) · The FASEB Journal · doi:10.1096/fj.201800579r · Cited by 43 · see citing works

Common characteristics and unique features: A comparison of the fusion machinery of the alphaherpesviruses Pseudorabies virus and Herpes simplex virus

Vallbracht, M., Backović, M., Klupp, B. G., Rey, F. A., & Mettenleiter, T. C. (2019) · Advances in virus research · doi:10.1016/bs.aivir.2019.05.007 · Cited by 41 · see citing works

Antibody recognition of the Pneumovirus fusion protein trimer interface

Huang, J., Diaz, D., & Mousa, J. J. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008942 · Cited by 43 · see citing works

50 Years of structural immunology

Wilson, I. A., & Stanfield, R. L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100745 · Cited by 43 · see citing works

Cryo-EM Structures Delineate a pH-Dependent Switch that Mediates Endosomal Positioning of SARS-CoV-2 Spike Receptor-Binding DomainsPreprint

Zhou, T., Tsybovsky, Y., Olia, A. S., Gorman, J., Rapp, M., Cerutti, G., Chuang, G., Katsamba, P. S., Nazzari, A. F., Sampson, J. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.04.187989 · Cited by 46 · see citing works

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate

Sliepen, K., Radić, L., Capella-Pujol, J., Watanabe, Y., Zon, I., Chumbe, A., Lee, W.-H., de Gast, M., Koopsen, J., Koekkoek, S. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34961-8 · Cited by 43 · see citing works

Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer

Bakkers, M. J. G., Ritschel, T., Tiemessen, M. M., Dijkman, J., Zuffianò, A. A., Yu, X., van Overveld, D., Le, L., Voorzaat, R., van Haaren, M. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50659-5 · Cited by 41 · see citing works

Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein

Cimica, V., Boigard, H., Bhatia, B., Fallon, J. T., Alimova, A., Gottlieb, P., & Galarza, J. M. (2016) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00720-15 · Cited by 41 · see citing works

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design

Rey-Jurado, E., & Kalergis, A. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030556 · Cited by 41 · see citing works

A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus

Lin, M., Yin, Y., Zhao, X., Wang, C., Zhu, X., Zhan, L., Chen, L., Wang, S., Lin, X. M., Zhang, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56302-1 · Cited by 40 · see citing works

Pre-fusion RSV F strongly boosts pre-fusion specific neutralizing responses in cattle pre-exposed to bovine RSV

Steff, A., Monroe, J. E., Friedrich, K., Chandramouli, S., Nguyên, T. L.-A., Tian, S., Vandepaer, S., Toussaint, J.-F., & Carfı́, A. (2017) · Nature Communications · doi:10.1038/s41467-017-01092-4 · Cited by 40 · see citing works

Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus

Boukhvalova, M. S., Yim, K. C., & Blanco, J. (2018) · Antiviral chemistry & chemotherapy · doi:10.1177/2040206618770518 · Cited by 40 · see citing works

Characterization of potent RSV neutralizing antibodies isolated from human memory B cells and identification of diverse RSV/hMPV cross-neutralizing epitopes

Xiao, X., Tang, A., Cox, K. S., Wen, Z., Callahan, C., Sullivan, N., Nahas, D. D., Cosmi, S. A., Galli, J. D., Minnier, M. A., et al. (2019) · mAbs · doi:10.1080/19420862.2019.1654304 · Cited by 40 · see citing works

Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation

Yú, L., Shao, S., Li, X. Y., Zhao, Z. X., Liu, N., Liu, Z. M., Shen, F. J., Zhang, H., Hou, J. W., Zhang, X. F., et al. (2024) · Science · doi:10.1126/science.adp2362 · Cited by 33 · see citing works

Generation of novel respiratory syncytial virus vaccine candidate antigens that can induce high levels of prefusion-specific antibodies

Matsuyama, R., Hogiri, T., Kishida, H., Takedomi, K., Okada, O., Nishizawa, A., Higashi-Nakatani, S., & Ōmasa, T. (2024) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2024.05.008

Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine

Che, Y., Gribenko, A. V., Song, X., Handke, L. D., Efferen, K. S., Tompkins, K. R., Kodali, S., Nuñez, L., Prasad, A. K., Phelan, L., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade6422 · Cited by 103 · see citing works

Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protection

Huang, Q.-L., Lang, Q., Li, Y., Wang, F., Han, X., Luo, L., Duan, X., Cao, X., Wang, Y., Bai, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63084-z · Cited by 9 · see citing works

Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability

Zhang, L., Dürr, E., Galli, J. D., Cosmi, S. A., Cejas, P. J., Luo, B., Touch, S., Parmet, P., Fridman, A., Espeseth, A. S., et al. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.032 · Cited by 30 · see citing works